Gapping down
In reaction to disappointing earnings/guidance: ATK -37.5%, CLB -15.5%, QCOM -8.3%, BABA -6%, QRVO -5.7%, VRTX -5.4%, (light volume), FTNT -5.4%, DWCH -5%, RCL -4.3%, GLOP -3.2%, EPD -2.9%, RDS.A -2.8%, TGI -2.7%, HSY -2.7%, ALXN -2.1%, QGEN -1.7%, PRXL -1.7%, RGLD -1.7%, BBD -1.6%, RTN -1.5%, ALGT -1.4%, KEX -1.3%, COLB -1.3%, FB -1.2%,ITG -1.2%, NOK -1%, TSCO -0.9%
Select metals/mining stocks trading lower: HMY -4%, DRD -3.8%, AG -3.8%, SLW -3.4%, GFI -3.2%, SVM -2.9%, GG -2.8%, HL -2.8%, AUY -2.7%, SLV -2.6%, SSRI -2.4%, GOLD -2.2%
Other news: APPY -70.6% (announces the FDA has determined that the APPY1 Test does not meet the criteria for substantial equivalence), GEVO -21.9% (intends to offer and sell common stock units; size not disclosed), HNR -20.5% (announces that its affiliates have withdrawn without prejudice a Request for Arbitration against the Government of the Bolivarian Republic of Venezuela),YHOO -5.5% (following BABA earnings), EXK -5.4% (updates NI 43-101 silver and gold reserve and resource estimates for its mines and exploration project in Mexico), MPET -4.9% (provides update on its CO2-enhanced oil recovery pilot at Poplar Dome in Montana), FRO -4.3% (announces the second amended and restated equity distribution agreement), REXR -3.1% (announces offering; 10 mln shares of common stock), TSM -3.1% (following QCOM results), PRE -3% (announced that during the January 1, 2015 treaty renewal season it expects to write and bind approximately $2.7 billion of Non-Life treaty premium), XNPT -2.7% (intends to offer $100 mln aggregate principal amount of convertible senior notes due 2022 in a private placement; disclosed that it expects to report that it had $102.1 mln of cash, cash equivalents and short-term investments as of December 31, 2014), MRTX -1.8% (intends to offer and sell shares of its common stock in an underwritten public offering; size not disclosed; disclosed that it estimates its cash, cash equivalents and marketable securities were ~$29.3 mln as of December 31, 2014)
Analyst comments: PBR -5.3% (downgraded to Underweight from Neutral at HSBC Securities), VIP -0.9% (downgraded to Hold from Buy at Deutsche Bank), HSBC -0.6% (downgraded to Underperform from Neutral at Exane BNP Paribas)
In reaction to disappointing earnings/guidance: ATK -37.5%, CLB -15.5%, QCOM -8.3%, BABA -6%, QRVO -5.7%, VRTX -5.4%, (light volume), FTNT -5.4%, DWCH -5%, RCL -4.3%, GLOP -3.2%, EPD -2.9%, RDS.A -2.8%, TGI -2.7%, HSY -2.7%, ALXN -2.1%, QGEN -1.7%, PRXL -1.7%, RGLD -1.7%, BBD -1.6%, RTN -1.5%, ALGT -1.4%, KEX -1.3%, COLB -1.3%, FB -1.2%,ITG -1.2%, NOK -1%, TSCO -0.9%
Select metals/mining stocks trading lower: HMY -4%, DRD -3.8%, AG -3.8%, SLW -3.4%, GFI -3.2%, SVM -2.9%, GG -2.8%, HL -2.8%, AUY -2.7%, SLV -2.6%, SSRI -2.4%, GOLD -2.2%
Other news: APPY -70.6% (announces the FDA has determined that the APPY1 Test does not meet the criteria for substantial equivalence), GEVO -21.9% (intends to offer and sell common stock units; size not disclosed), HNR -20.5% (announces that its affiliates have withdrawn without prejudice a Request for Arbitration against the Government of the Bolivarian Republic of Venezuela),YHOO -5.5% (following BABA earnings), EXK -5.4% (updates NI 43-101 silver and gold reserve and resource estimates for its mines and exploration project in Mexico), MPET -4.9% (provides update on its CO2-enhanced oil recovery pilot at Poplar Dome in Montana), FRO -4.3% (announces the second amended and restated equity distribution agreement), REXR -3.1% (announces offering; 10 mln shares of common stock), TSM -3.1% (following QCOM results), PRE -3% (announced that during the January 1, 2015 treaty renewal season it expects to write and bind approximately $2.7 billion of Non-Life treaty premium), XNPT -2.7% (intends to offer $100 mln aggregate principal amount of convertible senior notes due 2022 in a private placement; disclosed that it expects to report that it had $102.1 mln of cash, cash equivalents and short-term investments as of December 31, 2014), MRTX -1.8% (intends to offer and sell shares of its common stock in an underwritten public offering; size not disclosed; disclosed that it estimates its cash, cash equivalents and marketable securities were ~$29.3 mln as of December 31, 2014)
Analyst comments: PBR -5.3% (downgraded to Underweight from Neutral at HSBC Securities), VIP -0.9% (downgraded to Hold from Buy at Deutsche Bank), HSBC -0.6% (downgraded to Underperform from Neutral at Exane BNP Paribas)